genic mechanisms of diabetic nephropathy in order to develop targeted therapeutic agents with enhanced efficacy. Recent studies suggest that diabetic nephropathy is an inflammatory disease, and inflammatory mediators such as cytokines and chemokines play major roles in disease development and progression [4, 5] . Recent studies suggest the presence of endogenous pathways, such as netrin-1, that favorably regulate inflammation in diabetic nephropathy [6] . Deregulation of this protective pathway may accelerate disease development in the chronic diabetic milieu.
Netrin-1 is a laminin-related secreted molecule that has been identified as a neuronal guidance cue, directing neurons and their axons to targets during development of the nervous system. However, netrins are widely expressed outside the nervous system, including vascular endothelial [7, 8] and kidney tubular epithelial cells [8] , suggesting a broader role in regulating pathophysiology. Netrin-1 expression in vascular endothelial cells forms a critical barrier for leukocyte migration, and downregulation of netrin-1 exacerbates inflammation in acute models of organ injury [7, 8] . Netrin-1 mediates its biological activity by binding to two families of vertebrate receptors: the deleted in colorectal cancer (DCC) family and the uncoordinated-5 homolog (UNC5) family [9] . Several studies strongly suggest that the UNC5B receptor mediates the protective function of netrin-1 during acute kidney injury [10, 11] . Moreover, significant expression of UNC5B, but none of the other netrin receptors, was found in immune cells, endothelial cells and proximal renal tubular epithelial cells [10, 12] . Netrin-1 overexpression [6] or administration of recombinant netrin-1 [13] to a model of streptozotocin (STZ)-induced type 1 diabetic mice protected the kidney from inflammation, albuminuria and fibrosis. However, the receptor that mediates netrin-1 activity is unknown. Moreover, whether netrin-1 overexpression or administration of recombinant netrin-1 to a genetic model of type 1 diabetic mice and other nephropathy prone mice, such as the DBA strain, are also protective is unknown. The current study was carried out to answer these questions.
Material and Methods

Ethical Statement
All animal handling and procedures were performed in accordance with protocols for these studies that have been approved by the Institutional Animal Care and Use Committee at Georgia Regents University (Protocol #2011-0348). All experiments in animals were performed aseptically and every attempt was made to minimize pain and discomfort.
Mouse Strains
The generation of the UNC5B -flox alleles has been described previously [11, 14, 15] . GGT-cre mice were generously provided by Eric Nelson at Vanderbilt University School of Medicine. Genotypes were determined by PCR analysis of genomic DNA isolated from tail clips; amplification primers and conditions used for UNC5B mice were: 5 ′ -TAGCCTCAGGGTCTACTGTCTG-3 ′ ; 5 ′ -CTCTCAGACTTCTCAAAGAGATTC-3 ′ ; and 5 ′ -CCACTG TATGCCAGACGACATG-3 ′ under conditions of 94 ° C for 30 s, 62 ° C for 20 s and 72 ° C for 40 s. GGT-cre mice were genotyped using the primers: 5 ′ -AGGTGTAGAGAAGGCACTTAGC-3 ′ ; and 5 ′ -CTAATCGCCATCTTCCAGCAGG-3 ′ under conditions of 94 ° C for 30 s, 58 ° C for 20 s and 72 ° C for 40 s. The Institutional Animal Care and Use Committee of Georgia Regents University approved all of the protocols and procedures for using animals (approval number BR10-10-369).
Proximal Tubular Epithelial Cell-Specific Deletion of UNC5B
Creation and characterization of the UNC5B flox allele were described previously [14, 15] . To systematically inactivate UNC5B in a tissue-specific fashion, animals homozygous for the conditional allele (UNC5B flox/flox ) were mated with animals heterozygous for the UNC5B null allele (UNC5B +/-). The UNC5B flox/-progeny were mated with mice carrying the Cre gene under the control of gamma-glutamyl transferase (GGT) promoter whose activity was restricted to proximal tubular epithelial cells. The tubular-restricted GGT promoter was shown to be active only in adulthood but not during embryo development [16] . Deletion was confirmed by PCR and immunohistochemical staining of UNC5B in kidney sections ( fig. 1 ) as previously described [11] . Deletion of UNC5B in proximal tubular epithelial cells resulted in mice that survived to adulthood and that appeared to be normal.
STZ-Induced Diabetes
The diabetes induction protocol followed for mice was described by the Animal Models of Diabetic Complication Consortium (AMDCC) (http://www.diacomp.org/shared/protocols. aspx) [17] [18] [19] . Eight-week-old UNC5B flox/-/GGT-cre mice and littermates without cre (UNC5B flox/-) or wild-type (UNC5B flox/flox ) mice were given streptozotocin (STZ) (50 mg/kg body weight (BW) in citrate buffer) in multiple doses (every 24 h, total of five doses). Blood glucose and urine albumin were measured at 1 week after STZ injection and every four weeks thereafter. Relion glucose strips with Relion glucose monitor were used to measure the blood glucose in mice. About 6-10 animals/groups were used in all experiments.
Netrin-1 Transgenic Mice Backcrossed to DBA/2J
The DBA mouse strain is shown to have accelerated development of nephropathy and shows robust proteinuria [18, 19] . Therefore, we crossed transgenic mice that overexpress netrin-1 in proximal tubular epithelium under control of the L-fatty acid binding protein promoter [6, 20] with DBA/2J (Jackson Laboratories) mice. Six-week-old mice from the first generation (F1) that are positive and negative for the netrin-1 transgene were made diabetic using low-dose STZ (50 mg/kg BW/day for 5 days). Kidney function and proteinuria were monitored for another 8 weeks after the confirmation of diabetes. Urine was collected over a 24 h period and animals were sacrificed. Kidney tissues were processed for histopathological analysis.
Recombinant Netrin-1 Administration to Ins2Akita Mice
Male 12-week-old DBA/2J mice (wild-type or with the Akita mutation (JAX# 007562, D2.B6-Ins2Akita/MatbJ) were purchased from Jackson Laboratories. Mice with the Akita mutation developed diabetes when they are 4 weeks old. At the age of 12 weeks, Akita mice were treated with recombinant human netrin-1 (5 μg/ animal/every 48 h, intraperitoneally) or vehicle (0.1% BSA) for a period of 6 weeks. 24 h urine was collected for determining the albumin excretion rate. Animals were sacrificed to collect plasma and kidney tissues, which were fresh-frozen for analysis of gene expression or histopathological analysis.
Measurement of Urine Albumin Excretion Rate (AER)
Excretion of urinary albumin was determined using the albumin-to-creatinine ratio (ACR) in 24 h urine collections. The 24 h urine was collected using the Nalgene ® Metabolic Cage System (Rochester, N.Y., USA), which is designed to allow efficient separation of urine and feces from a single mouse. The concentration of albumin in urine was quantified using an ELISA kits (Bethyl Laboratories, Inc., Montgomery, Tex., USA), and urine creatinine was determined by using a creatinine assay kit (Diazyme Laboratories, Poway, Calif., USA).
Cytokine and Chemokine Measurements
Cytokines and chemokines in serum and urine were measured using an ELISA array kit from eBioscience.
Histological Analysis
Kidney tissue was fixed in buffered 10% formalin for 12 h and then embedded in paraffin wax. For assessment of injury, 5 μ M sections were stained with periodic acid-Schiff (PAS) followed by hematoxylin. To assess fibrosis in the kidney, kidney tissue sec- 223 tions were stained with Trichrome. Stained sections were photographed using an Olympus inverted microscope with a color CCD camera.
Glomerular Morphometry
At the time of sacrifice, kidneys were harvested for pathological examination. One kidney was fresh-frozen for gene expression analysis, and the other was fixed in 10% neutral-buffered formalin (Sigma-Aldrich Co., St. Louis, Mo., USA). The formalin-fixed tissue was embedded in paraffin, and 4-μm sections were stained with periodic acid-Schiff stain (American Histolabs, Gaithersburg, Md., USA). Glomerular sclerosis was quantified using a semi-automatic image analysis technique with an examination of the total cortical area. To perform morphologic analyses, a total of 30 glomeruli were randomly selected from each kidney by moving the slide from the outer to the inner cortex in a random fashion to obtain non-overlapping sample fields. Glomerular images were recorded using a CCD camera (Olympus DP72 color CCD camera) (Olympus USA, Pittsburg, Pa., USA) mounted on an Olympus light microscope. The glomerular tuft was traced, and the enclosed area was calculated with Cellsens Standard software.
For quantification of mesangial extracellular matrix, 3-μm sections from paraformaldehyde-fixed, paraffin-embedded kidney slices were stained using PAS. Mesangial area was expressed quantitatively by calculating the percentage of the total glomerular area that was PAS positive and nucleus free area [21, 22] . Fifteen glomerular tufts per animal were chosen randomly for analysis.
Statistical Analysis
Data are presented as the mean ± SEM. p < 0.05 was considered significant. Statistical analyses were performed using Graphpad Instat 3 (GraphPad Software, San Diego, Calif., USA). All assays were performed in duplicate or triplicate. Statistical significance was assessed by an unpaired, two-tailed Student t-test for single comparison or ANOVA for multiple comparisons.
Results
Proximal Tubular Epithelial Cell-Specific Deletion of UNC5B in Mice Exacerbate Diabetes-Induced Albuminuria
To determine the role of the tubular epithelial UNC5B receptor in chronic kidney disease, such as diabetic nephropathy, mice with the UNC5B flox/-/GGT-cre allele and littermates without cre (UNC5B flox/-) or wild-type were made diabetic as described in Materials and Methods. Buffer-treated, non-diabetic control animals did not show any increase in blood glucose level or increase in albuminuria ( fig. 2 a-c) . However, diabetic wild-type mice and heterozygous knockout mice (UNC5B flox/-) showed a significant increase in albuminuria as compared to non-diabetic controls. Interestingly, the increase in albuminuria was much more pronounced in UNC5B flox/-/GGT-cre mice ( fig. 2 a and b) , suggesting that UNC5B signaling in proximal tubular epithelium may play an important role in controlling diabetes-induced albuminuria. Blood glucose level and kidney hypertrophy were increased significantly in all three groups over controls, but no differences were seen among the diabetic groups. Consistent with albuminuria, PAS-stained sections showed expansion of the mesangial matrix and deposition of proteinaceous materials in the glomerulus in diabetic animals, which was more pronounced in UNC5B flox/-/GGT-cre mice ( fig. 3 ) .
Effects of Netrin-1 Overexpression in Tubular Epithelium in the Nephropathy Prone DBA Mouse Background on Albuminuria
Previous studies had shown that netrin-1 overexpression in proximal tubular epithelium is protective against diabetic nephropathy in the CB57BL/6 background strain, which showed a mild form of nephropathy [6] . To determine whether netrin-1 offers protection against diabetes-induced albuminuria in the nephropathy-prone DBA mouse background, we performed an F1 backcross as described in Materials and Methods. As shown in figure 4 , no difference was observed between wild-type (WT) and netrin-1 transgenic mice for blood glucose level ( fig. 4 a) and kidney weight/body weight ratio ( fig. 4 b) after induction of diabetes. However, wild-type mice showed a significant increase in albuminuria over control. These changes were significantly reduced in netrin-1 transgenic diabetic animals ( fig. 4 d) , suggesting netrin-1 is protective even in the nephropathy-prone mouse background. Consistent with albuminuria, the PASstained sections showed an increase in glomerular area ( fig. 4 f) and mesangial expansion ( fig. 4 e and g ) in wildtype kidney but not in the netrin-1 transgenic kidney.
Inflammation is a mediator of diabetic nephropathy. Previous studies had demonstrated that netrin-1 regulates inflammation in diabetes [6] . Consistent with previous studies, the excretion of IL-6 and TNFα was significantly increased in diabetic mice ( fig. 5 a and b) . However, excretion of these cytokines was significantly lower in netrin-1 transgenic diabetic mice (Tg3-DBA mice) as compared to wild-type diabetic mice. To determine whether kidney specific overexpression of netrin-1 has any influence on systemic inflammation, IL-6 and TNFα in serum was quantified. IL-6 level was significantly elevated in WT with diabetes. However, overexpression of netrin-1 in the kidney did not alter serum IL-6 levels ( fig. 5 c) . TNFα level in serum was not increased significantly in both WT and netrin-1 transgenic diabetic mice over control mice ( fig. 5 d) . These data suggest that kidney epithelium specific overexpression of netrin-1 does not alter systemic inflammation in diabetes.
Effect of Recombinant Netrin-1 Administration on Albuminuria in Ins2Akita Diabetic Mice
To translate our finding, we administered recombinant netrin-1 to the most widely used type 1 diabetic mouse model for nephropathy as described in Materials and Methods. As shown in figure 6 a, vehicle treated Ins2Akita mice showed a large increase in albumin excretion rate as compared to the wild-type control. Administration of netrin-1 significantly suppressed albumin excretion as compared to vehicle-treated animals. Blood glucose ( fig. 6 b) and urine glucose levels ( fig. 6 c) were elevated in both vehicle and netrin-1 treated Ins2Akita mice as compared to wild-type control. However, the diabetes-induced increased kidney hypertrophy was significantly reduced with netrin-1 treatment. Consistent with the suppression of albumin excretion Proximal tubule-specific deletion of UNC5B exacerbates diabetes-induced albuminuria. Mice with whole body, partial (one allele) (flox/-), or total (flox/-/GGT-cre) deletion of UNC5B in the proximal tubules, or their wild type (flox/flox) controls, were made diabetic as described in Materials and Methods. Eight weeks after induction of diabetes, albuminuria and kidney hypertrophy changes were assessed. a , b Diabetes-induced albuminuria expressed as albumin excretion rate (AER). Significant increase of AER in diabetic mice was seen as compared to non-diabetic controls. Flox/-/GGT-cre mice showed exacerbated albuminuria as compared to diabetic WT and heterozygous UNC5B KO (flox/-) mice. * p < 0.01 versus control. # p < 0.05 versus other diabetic groups. n = 6-8. c Blood glucose levels were equally elevated in all three groups of diabetic mice. * p < 0.001 versus control. d Kidney hypertrophy is significantly increased in all three groups, and UNC5B deletion did not alter the diabetes-induced kidney hypertrophy. * p < 0.05 versus control. . DBA/netrin-1 transgenic (Tg3) diabetic mice excrete low levels of pro-inflammatory cytokines. F1 mice expressing the netrin-1 transgene and WT mice were made diabetic by low-dose STZ administration. IL-6 and TNFα excretion in urine were measured 8 weeks after the induction of diabetes and expressed as pg/ mg of urine creatinine. a Diabetes-induced increase in IL-6 excretion in WT mice was significantly suppressed in Tg3-DBA mice.
* p < 0.01 versus controls. # p < 0.001 versus WT diabetic mice. b Diabetes-induced increase in TNFα excretion in WT mice was significantly suppressed in Tg3-DBA mice. * p < 0.01 versus controls. # p < 0.001 versus WT diabetic mice. c Diabetes-induced increase in serum IL-6 levels in both WT and Tg3-DBA mice significantly. * p < 0.05 versus controls. d Diabetes does not alter serum TNFα levels in both WT and Tg3-DBA mice. n = 6-10. with netrin-1 treatment, both tubular and glomerular alterations such as fibrosis, dilation of tubules and mesangial expansion were suppressed with netrin-1 treatment ( fig. 6 e and f).
Discussion
Endogenous protective pathways that counteract to suppress excess inflammation and cellular injury exist or are induced during acute or chronic disease conditions. One such pathway is netrin-1 and its receptor. This protective pathway was shown to play an important role in many acute and chronic diseases [6, 10, 20, [23] [24] [25] [26] . Currently available therapeutics such as blood pressure control and intense glucose control are not able to reverse the disease process once diabetic nephropathy is established. Efforts to develop new therapies have been hindered by the lack of complete knowledge on protective pathways such as netrin-1 and UNC5B. In this study, we combined genetic and pharmacologic approaches to investigate the functional role of the neuronal guidance molecule ne- trin-1 and its receptor during diabetic nephropathy. Our findings suggest that renal epithelial cell specific deletion of the netrin-1 receptor UNC5B caused a far more severe course of kidney disease during STZ-induced diabetes mellitus as compared to diabetic littermate wild-type and heterozygous knockout (UNC5B-/+) mice. Overexpression of netrin-1 in the nephropathy prone mouse strain (DBA/2J) causes significant suppression of disease severity. Finally, recombinant netrin-1 administration to a genetic model of diabetic nephropathy (Ins2Akita) revealed robust treatment effects as shown by attenuated disease severity in all parameters that we assessed. Taken together, these studies indicate, for the first time, a protective role of UNC5B receptor signaling during diabetic nephropathy. Previous studies from laboratory had suggested that UNC5B deletion in proximal tubular epithelium exacerbated acute kidney injury by increasing epithelial cell apoptosis and inflammation [11] . Consistent with these findings, the present study demonstrates that UNC5B signaling is critical even for chronic kidney disease. Two recent studies also demonstrated protective effects of netrin-1 using two different approaches. One study used overexpression in tubular epithelium [6] , and the other study used heterozygous knockout mice and recombinant netrin-1 administration [13] . Both studies employed an STZ-induced mild form of nephropathy in a C57BL/6 background strain. It was demonstrated that netrin-1 suppresses albuminuria, in part, through the suppression of COX-2 expression and suppresses inflammation through the inhibition of NFκB activation [6] . Moreover, netrin-1 also increased albumin uptake by epithelial cells. Therefore, it is possible that netrin-1 may suppress nephropathy through UNC5B by suppressing tubular epithelial damage and enhanced clearance of albumin from the lumen. This will reduce epithelial stress and inflammation, which will impact on podocyte function. Previous studies, however, examined nephropathy in C57BL/6 mouse background, which is known to have a mild form of nephropathy and proteinuria [18, 19, 27] . It was not clear whether netrin-1 can be protective in a more nephropathy-prone mouse background such as DBA and Ins2Akita. Data presented in this manuscript suggest that netrin-1 is capable of protecting the kidney against diabetes-induced albuminuria and glomerulosclerosis even in a more nephropathy-prone mouse background. Moreover, netrin-1 may regulate inflammatory cytokine production, thereby reducing the development of nephropathy.
In conclusion, this study on the role of netrin-1 signaling during diabetic nephropathy demonstrated a protective role of the endogenous netrin-1 receptor UNC5B in attenuating disease severity. Moreover, tubular epithelial cell-derived netrin-1 may play a critical role in attenuating disease severity. Our study also demonstrated that the administration of netrin-1 could be therapeutic against diabetic nephropathy.
